ReviewTherapeutic advances in medical oncology2017

Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting.

Javier Puente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.